| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.00077 | 1 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.00061 | 1 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.00057 | 1 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.00053 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.00054 | 1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.00042 | 1 |